NCT02863445View on ClinicalTrials.gov

Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

July 6, 2017

Primary Completion Date

January 16, 2021

Study Completion Date

August 16, 2021

Conditions
Obesity
Interventions
DRUG

Levonorgestrel-based emergency contraception 1.5 mg

Evaluating pharmacodynamic outcomes in obese women using 1.5mg versus 3.0mg of LNG-based EC

DRUG

Levonorgestrel-based emergency contraception 3.0mg

Evaluating pharmacodynamic outcomes in obese women using 1.5mg versus 3.0mg of LNG-based EC

Trial Locations (1)

97239

OHSU, Portland

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Oregon Health and Science University

OTHER

NCT02863445 - Effectiveness of Orally Dosed Emergency Contraception in Obese Women - LNG | Biotech Hunter | Biotech Hunter